hero section gradient
17 handpicked stocks

Century Club

These companies have stood the test of time for over 100 years. Carefully selected by our analysts, this collection showcases businesses with proven resilience, established market positions, and the ability to deliver returns across multiple economic cycles.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Analysis of the Century Club basket total market capitalisation and stock breakdown.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility, greater stability, and closer tracking of broad market movements.
  • Use this basket primarily as a diversified core holding rather than a speculative, high-growth allocation.
  • Expect steady long-term appreciation tendencies rather than explosive short-term gains; outcomes are not guaranteed.
Total Market Cap
  • KO: $306.39B

  • JPM: $816.92B

  • PG: $354.86B

  • Other

About This Group of Stocks

1

Our Expert Thinking

This collection represents corporate longevity champions that have weathered everything from world wars to the digital revolution. Their demonstrated ability to adapt through profound economic shifts and technological changes offers a unique form of stability that's rare in today's market.

2

What You Need to Know

Century Club companies span foundational sectors like manufacturing, transportation, consumer goods, and financial services. They typically feature strong brand recognition, established supply chains, and significant pricing power—advantages that help them navigate inflation and market uncertainty.

3

Why These Stocks

Each company was specifically selected for maintaining continuous operations for over 100 years—an extraordinary achievement that demonstrates sustainable business models and strategic adaptability. In a portfolio, they can provide a stabilizing element against market volatility.

Why You'll Want to Watch These Stocks

🛡️

Recession-Tested Winners

These companies have survived the Great Depression, multiple recessions, and market crashes. Their proven resilience makes them particularly attractive during economic uncertainty.

💰

Dividend Dynamos

Many Century Club companies have paid consistent dividends for decades, some for over 100 consecutive years. This income potential adds another dimension to their investment appeal.

🏆

The 1% Club

Less than 1% of companies survive a century of operation. These rare businesses have demonstrated exceptional staying power that countless competitors couldn't match.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions